Juergen Wolf

6.9k citations
94 papers · 1.9k · 1 hit paper · h-index 24

Impact in

Papers in

    • Lung Cancer Treatments and Mutations 58
    • Lung Cancer Diagnosis and Treatment 15
    • Lung Cancer Research Studies 22
    • Colorectal Cancer Treatments and Studies 16
    • Cancer Immunotherapy and Biomarkers 6

Juergen Wolf

87 papers receiving 1.8k citations

Juergen Wolf's Hit Papers

Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non–Small Cell Lung Cancer 2017 · 254 citations
2540+3+6Years since publication50100150200250

Peers

Juergen Wolf
Comparison fields: 5 of 82
  • Oncology 854
  • Pulmonary and Respiratory Medicine 844
  • Pathology and Forensic Medicine 309
  • Cancer Research 236
  • Genetics 85
Replace Katherine Liau with:
Katherine Liau United States
Christian Rothermundt Switzerland
Karina Vera United States
Gianluca Spitaleri Italy
Giuseppe Lo Russo Italy
Annamaria H. Zimmermann United States
Ian M. Waxman United States
Joaquina Baranda United States
Yung‐Jue Bang South Korea
Lucia Nogová Germany
Juergen Wolf relative to Katherine Liau United States Katherine Liau's profile →
Citations per field
00.5×10×
Katherine Liau · 1×
Citations per year

Countries citing papers authored by Juergen Wolf

Since Specialization
Citations

This map shows the geographic impact of Juergen Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juergen Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juergen Wolf more than expected).

Fields of papers citing papers by Juergen Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juergen Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juergen Wolf. The network helps show where Juergen Wolf may publish in the future.

Co-authors

The 25 scholars most cited alongside Juergen Wolf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Juergen Wolf Line = papers co-authored together Juergen Wolf links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non–Small Cell Lung Cancer
Hit paper breakdown →
2017254
2 2003116
3 2019111
4 200389
5 202087
6 201985
7 200582
8 200559
9 201159
10 201350
11 201848
12 202046
13 201946
14 201445
15 201637
16 201135
17 201435
18
Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors
201430
19 201728
20 201026

About Juergen Wolf

Juergen Wolf is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 94 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (58 papers), Cancer Genomics and Diagnostics (25 papers), Lung Cancer Research Studies (22 papers), Colorectal Cancer Treatments and Studies (16 papers), Lung Cancer Diagnosis and Treatment (15 papers), Radiomics and Machine Learning in Medical Imaging (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Fibroblast Growth Factor Research (5 papers). The work is most often cited by research in Oncology (854 citations), Pulmonary and Respiratory Medicine (844 citations), Pathology and Forensic Medicine (309 citations), Cancer Research (236 citations) and Genetics (85 citations). Juergen Wolf has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Volker Diehl, Michael Hallek, Johan Vansteenkiste, Enriqueta Felip, Daniel Shao-Weng Tan, Jan Gaertner, Raymond Voltz, Egbert F. Smit, Gregory J. Riely and Jan‐Peter Glossmann. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Cancer Research, The Lancet Respiratory Medicine and Supportive Care in Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact